2022-11-10

Camurus' Interim Report for third quarter 2022

Lab Work

Camurus' Interim Report for the third quarter, which was published today, showed that this was Camurus' financially best quarter to date.

Read the full press release on Camurus' website:

Camurus’ Interim Report Third Quarter 2022 - Camurus

Latest news

2019-04-10

Aimpoint granted new large FCS contract from the U.S. Military

Aimpoint has been awarded a large contract of USD 24 million from the U.S. Military for the FCS13-RE system for SAAB…

Read more

2019-04-10

Camurus’ rights issue oversubscribed

Camurus’ rights issue of 403 MSEK has been oversubscribed. The rights issue was carried out to secure financing of t…

Read more

2019-04-10

Positive results for Buvidal® in treatment for fentanyl dependence

New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl…

Read more

2019-04-10

Court proceedings initiated for immediate market approval of Brixadi™ in the US

Camurus’ partner, Braeburn Inc., has initiated court proceedings foran approval of Brixadi (Buvidal® in the US) and…

Read more

2019-02-26

Spin-off of GAIM from Aimpoint

Based on Aimpoint's red dot sight for fire arms, the company has developed a commercial VR platform, GAIM, which is…

Read more